BC Extra | Mar 8, 2019
Company News

Merck partners with King’s College to develop non-opioid pain therapies

Merck has partnered with King's College London to translate research elucidating HCN2 as a pain target to develop non-opioid treatments for chronic neuropathic pain. The deal builds on work from the lab of Peter McNaughton...
BC Innovations | Jun 29, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: June 2017

New Therapeutic Targets and Biomarkers: June 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during June 2017. Therapeutic targets are defined as any protein, gene or other...
BC Innovations | Jun 27, 2017
Distillery Techniques


TECHNOLOGY: SNPs SNPs on LINC00477 and HCN4 could help predict the risk of atrial fibrillation. Genome-wide association studies in a total of 53,174 individuals of European ancestry identified associations between low heart rate variability and...
Items per page:
1 - 3 of 3